Methods and compositions for the treatment of seizure-related disorders
US10973783B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2016 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | Dec 30, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1635
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods are provided for administering a pharmaceutical composition to a human patient. Compositions are administered to a human patient orally, once daily, at a therapeutically effective dose. The pharmaceutical compositions comprise a drug selected from the group consisting of brivaracetam, divalproex, lacosamide, levetiracetam, oxcarbazepine, vigabatrin, and pharmaceutically acceptable salts of any of the foregoing, and at least one excipient. At least one of said at least one excipients modifies the release of said drug to provide an extended release form. The pharmaceutical composition have pharmacokinetic properties recited in the claims.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.